anmelden
SLI
2.107,04
PKT
+5,28
PKT
+0,25
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.07.21 | Novartis Buy | UBS AG | |
| 23.07.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 23.07.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 23.07.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 23.07.21 | Givaudan Add | Baader Bank | |
| 23.07.21 | UBS Sector Perform | RBC Capital Markets | |
| 23.07.21 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 22.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | Novartis Hold | Deutsche Bank AG | |
| 22.07.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.07.21 | Roche Neutral | UBS AG | |
| 22.07.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
| 22.07.21 | Givaudan Add | Baader Bank | |
| 22.07.21 | Roche Buy | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.07.21 | Givaudan Underperform | Bernstein Research | |
| 22.07.21 | Roche Outperform | Bernstein Research | |
| 22.07.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 22.07.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 22.07.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Holcim Buy | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.21 | UBS Outperform | Credit Suisse Group | |
| 21.07.21 | UBS Underweight | Barclays Capital | |
| 21.07.21 | Zurich Insurance Overweight | Morgan Stanley | |
| 21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Buy | UBS AG | |
| 21.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 21.07.21 | Kühne + Nagel International Neutral | JP Morgan Chase & Co. | |
| 20.07.21 | UBS Buy | Jefferies & Company Inc. | |
| 20.07.21 | UBS Overweight | JP Morgan Chase & Co. | |
| 20.07.21 | UBS Sector Perform | RBC Capital Markets | |
| 20.07.21 | Nestlé Add | Baader Bank |